Lun X, Sheng K, Yu X, Lam C, Gowri G, Serrata M
Nat Biotechnol. 2024; .
PMID: 39075149
DOI: 10.1038/s41587-024-02316-x.
Spasic M, Ogayo E, Parsons A, Mittendorf E, van Galen P, McAllister S
Cancer Res Commun. 2024; 4(3):895-910.
PMID: 38466569
PMC: 10962315.
DOI: 10.1158/2767-9764.CRC-23-0357.
van der Pan K, Khatri I, de Jager A, Louis A, Kassem S, Naber B
Front Immunol. 2023; 14:1191992.
PMID: 37275858
PMC: 10235610.
DOI: 10.3389/fimmu.2023.1191992.
Jaimes M, Leipold M, Kraker G, Amir E, Maecker H, Lannigan J
Cytometry A. 2022; 101(11):942-959.
PMID: 35593221
PMC: 9790709.
DOI: 10.1002/cyto.a.24565.
Abrecht C, Hallisey M, Dennis J, Nazzaro M, Brainard M, Hathaway E
STAR Protoc. 2022; 3(2):101362.
PMID: 35573480
PMC: 9092992.
DOI: 10.1016/j.xpro.2022.101362.
Unsupervised Analysis of Flow Cytometry Data in a Clinical Setting Captures Cell Diversity and Allows Population Discovery.
Baumgaertner P, Sankar M, Herrera F, Benedetti F, Barras D, Thierry A
Front Immunol. 2021; 12:633910.
PMID: 33995353
PMC: 8119773.
DOI: 10.3389/fimmu.2021.633910.
Measuring single-cell protein secretion in immunology: Technologies, advances, and applications.
Bucheli O, Sigvaldadottir I, Eyer K
Eur J Immunol. 2021; 51(6):1334-1347.
PMID: 33734428
PMC: 8252417.
DOI: 10.1002/eji.202048976.
Full Spectrum Flow Cytometry as a Powerful Technology for Cancer Immunotherapy Research.
Bonilla D, Reinin G, Chua E
Front Mol Biosci. 2021; 7:612801.
PMID: 33585561
PMC: 7878389.
DOI: 10.3389/fmolb.2020.612801.
Single Cell Detection of the p53 Protein by Mass Cytometry.
Fagerholt O, Hellesoy M, Gullaksen S, Gjertsen B
Cancers (Basel). 2020; 12(12).
PMID: 33317179
PMC: 7764694.
DOI: 10.3390/cancers12123699.
SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.
Hu-Lieskovan S, Bhaumik S, Dhodapkar K, Grivel J, Gupta S, Hanks B
J Immunother Cancer. 2020; 8(2).
PMID: 33268350
PMC: 7713206.
DOI: 10.1136/jitc-2020-000705.
OMIP-069: Forty-Color Full Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Major Cell Subsets in Human Peripheral Blood.
Park L, Lannigan J, Jaimes M
Cytometry A. 2020; 97(10):1044-1051.
PMID: 32830910
PMC: 8132182.
DOI: 10.1002/cyto.a.24213.
The role of automated cytometry in the new era of cancer immunotherapy.
Danova M, Torchio M, Comolli G, Sbrana A, Antonuzzo A, Mazzini G
Mol Clin Oncol. 2018; 9(4):355-361.
PMID: 30233791
PMC: 6142305.
DOI: 10.3892/mco.2018.1701.
CyTOF Measurement of Immunocompetence Across Major Immune Cell Types.
Subrahmanyam P, Maecker H
Curr Protoc Cytom. 2017; 82:9.54.1-9.54.12.
PMID: 28967988
PMC: 5678938.
DOI: 10.1002/cpcy.27.
The Society for Immunotherapy of Cancer Biomarkers Task Force recommendations review.
Butterfield L
Semin Cancer Biol. 2017; 52(Pt 2):12-15.
PMID: 28943324
PMC: 5862764.
DOI: 10.1016/j.semcancer.2017.09.006.
Immunotherapy biomarkers 2016: overcoming the barriers.
Gulley J, Berzofsky J, Butler M, Cesano A, Fox B, Gnjatic S
J Immunother Cancer. 2017; 5(1):29.
PMID: 28653584
PMC: 5359902.
DOI: 10.1186/s40425-017-0225-6.
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.
Gnjatic S, Bronte V, Rosa Brunet L, Butler M, Disis M, Galon J
J Immunother Cancer. 2017; 5:44.
PMID: 28515944
PMC: 5432988.
DOI: 10.1186/s40425-017-0243-4.
Systematic evaluation of immune regulation and modulation.
Stroncek D, Butterfield L, Cannarile M, Dhodapkar M, Greten T, Grivel J
J Immunother Cancer. 2017; 5:21.
PMID: 28331613
PMC: 5359947.
DOI: 10.1186/s40425-017-0223-8.
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy.
Ma W, Gilligan B, Yuan J, Li T
J Hematol Oncol. 2016; 9(1):47.
PMID: 27234522
PMC: 4884396.
DOI: 10.1186/s13045-016-0277-y.